Short Bowel Syndrome News and Research

RSS
Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Novel robot can aid treatment of rare birth defect

Novel robot can aid treatment of rare birth defect

Implanted robotic system stimulates tissue growth in stunted organs

Implanted robotic system stimulates tissue growth in stunted organs

Implanted robots could help grow esophagus and gut

Implanted robots could help grow esophagus and gut

Researchers map genetic changes resulting from short bowel syndrome

Researchers map genetic changes resulting from short bowel syndrome

Scientists bridge gap between two separate pieces of embryonic mouse intestine

Scientists bridge gap between two separate pieces of embryonic mouse intestine

CHLA researchers provide new hope for infants with short bowel syndrome

CHLA researchers provide new hope for infants with short bowel syndrome

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Scientists reveal how breast milk prevents necrotizing enterocolitis in premature babies

Scientists reveal how breast milk prevents necrotizing enterocolitis in premature babies

CHLA scientists grow tissue-engineered small intestine from human cells

CHLA scientists grow tissue-engineered small intestine from human cells

SSEF protocol reduces incidence of NEC or death in infants with extremely low birth weight

SSEF protocol reduces incidence of NEC or death in infants with extremely low birth weight

First three recipients of inaugural Harry Winston Fellowships named

First three recipients of inaugural Harry Winston Fellowships named

Oxabact now recognized as potential treatment for Short Bowel Syndrome

Oxabact now recognized as potential treatment for Short Bowel Syndrome

NPS Pharmaceuticals reports net global product sales of $15.3 million for Q4 2013

NPS Pharmaceuticals reports net global product sales of $15.3 million for Q4 2013

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Intravenous feeding can cause liver damage, say researchers

Intravenous feeding can cause liver damage, say researchers

Teduglutide offers relief for patients with short-bowel syndrome

Teduglutide offers relief for patients with short-bowel syndrome

Nanofiber Solutions wins Ohio Third Frontier Technology Validation and Start-up Fund award

Nanofiber Solutions wins Ohio Third Frontier Technology Validation and Start-up Fund award

Parenteral nutrition safety: an interview with Dr. Phil Ayers, A.S.P.E.N PN Safety Task Force Chair and Dr. Peggi Guenter, Director of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

Parenteral nutrition safety: an interview with Dr. Phil Ayers, A.S.P.E.N PN Safety Task Force Chair and Dr. Peggi Guenter, Director of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

Longer looks: A key Hagel mission is to cut military health costs; Medical lessons from a mother's death; How they price - and how we pay for -a $300,000 medicine

Longer looks: A key Hagel mission is to cut military health costs; Medical lessons from a mother's death; How they price - and how we pay for -a $300,000 medicine